Reference
- Álvarez-Garcia, V., Tawil, Y., Wise, H. M., & Leslie, N. R. (2019). Mechanisms of PTEN loss in cancer: It’s all about diversity. Seminars in Cancer Biology, 59, 66–79. https://doi.org/https://doi.org/10.1016/j.semcancer.2019.02.001
- Anand, K., Naicker, T., Baijnath, S., Mphahlele, M. J., Katari, N. K., Zamisa, S. J., Balakumar, C., Vijayakumar, K., Palanisamy, S., Saravanan, M., Boomi, P., & Chuturgoon, A. (2020). TPGS-mediated one-pot synthesis, XRD structural analysis, antimicrobial evaluation and molecular docking of novel heterocycles as potential inhibitors of p53-MDM2 protein. Journal of Molecular Structure, 1202, 127252. https://doi.org/https://doi.org/10.1016/j.molstruc.2019.127252
- Balakumar, C., Kishore, D. P., Rao, K. V., Narayana, B. L., Rajwinder, K., Rajkumar, V., & Rao, A. R. (2012). Design, microwave-assisted synthesis and in silico docking studies of new 4H-pyrimido [2,1-b]benzothiazole-2-arylamino-3-cyano-4-ones as possible adenosine A2B receptor antagonists. ChemInform, 43(48), 1113. https://doi.org/https://doi.org/10.1002/chin.201248173
- Balakumar, C., Lamba, P., Kishore, D. P., Narayana, B. L., Rao, K. V., Rajwinder, K., Rao, A. R., Shireesha, B., & Narsaiah, B. (2010). Synthesis, anti-inflammatory evaluation and docking studies of some new fluorinated fused quinazolines. European Journal of Medicinal Chemistry, 45(11), 4904–4913. https://doi.org/https://doi.org/10.1016/j.ejmech.2010.07.063
- Balakumar, C., Ramesh, M., Tham, C. L., Khathi, S. P., Kozielski, F., Srinivasulu, C., Hampannavar, G. A., Sayyad, N., Soliman, M. E., & Karpoormath, R. (2018). Ligand- and structure-based in silico studies to identify kinesin spindle protein (KSP) inhibitors as potential anticancer agents. Journal of Biomolecular Structure & Dynamics, 36(14), 3687–3704. https://doi.org/https://doi.org/10.1080/07391102.2017.1396255
- Bathini, R., Sivan, S. K., Fatima, S., & Manga, V. (2016). Molecular docking, MM/GBSA and 3D-QSAR studies on EGFR inhibitors. Journal of Chemical Sciences, 128(7), 1163–1173. https://doi.org/https://doi.org/10.1007/s12039-016-1103-3
- Bonneau, D., & Longy, M. (2000). Mutations of the human PTEN gene. Human Mutation, 16(2), 109–122. https://doi.org/https://doi.org/10.1002/1098-1004(200008)16:2 < 109::aid-humu3 > 3.0.co;2-0
- Chen, F., Ma, K., Zhang, L., Madajewski, B., Turker, M. Z., Gallazzi, F., Cruickshank, K., Zhang, X., Jenjitranant, P., Touijer, K. A., Quinn, T. P., Zanzonico, P., Wiesner, U., & Bradbury, M. S. (2019). Ultrasmall renally clearable silica nanoparticles target prostate cancer. ACS Applied Materials & Interfaces, 11(47), 43879–43887. https://doi.org/https://doi.org/10.1021/acsami.9b15195
- Cheng, F., Li, W., Liu, G., & Tang, Y. (2013). In silico ADMET prediction: Recent advances, current challenges and future trends. Current Topics in Medicinal Chemistry, 13(11), 1273–1289. https://doi.org/https://doi.org/10.2174/15680266113139990033
- Cherukupalli, S., Chandrasekaran, B., Aleti, R. R., Sayyad, N., Hampannavar, G. A., Merugu, S. R., Rachamalla, H. R., Banerjee, R., & Karpoormath, R. (2019). Synthesis of 4,6-disubstituted pyrazolo[3,4-d]pyrimidine analogues: Cyclin-dependent kinase 2 (CDK2) inhibition, molecular docking and anticancer evaluation. Journal of Molecular Structure, 1176, 538–551. https://doi.org/https://doi.org/10.1016/j.molstruc.2018.08.104
- Daina, A., Michielin, O., & Zoete, V. (2017). SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific Reports, 7, 42717–42713. https://doi.org/https://doi.org/10.1038/srep42717
- Daina, A., & Zoete, V. (2016). A BOILED-Egg to predict gastrointestinal absorption and brain penetration of small molecules. ChemMedChem, 11(11), 1117–1121. https://doi.org/https://doi.org/10.1002/cmdc.201600182
- Duan, M., Liu, N., Zhou, W., Li, D., Yang, M., & Hou, T. (2016). Structural diversity of ligand-binding androgen receptors revealed by microsecond long molecular dynamics simulations and enhanced sampling. Journal of Chemical Theory and Computation, 12(9), 4611–4619. https://doi.org/https://doi.org/10.1021/acs.jctc.6b00424
- Erdogan, S., Doganlar, O., Doganlar, Z. B., & Turkekul, K. (2018). Naringin sensitizes human prostate cancer cells to paclitaxel therapy. Prostate International, 6(4), 126–135. https://doi.org/https://doi.org/10.1016/j.prnil.2017.11.001
- Ferroni, C., Pepe, A., Kim, Y. S., Lee, S., Guerrini, A., Parenti, M. D., Tesei, A., Zamagni, A., Cortesi, M., Zaffaroni, N., De Cesare, M., Beretta, G. L., Trepel, J. B., Malhotra, S. V., & Varchi, G. (2017). 1,4-Substituted triazoles as nonsteroidal anti-androgens for prostate cancer treatment. Journal of Medicinal Chemistry, 60(7), 3082–3093. https://doi.org/https://doi.org/10.1021/acs.jmedchem.7b00105
- Ganai, S. A., Farooq, Z., Banday, S., & Altaf, M. (2018). In silico approaches for investigating the binding propensity of apigenin and luteolin against class i HDAC isoforms. Future Medicinal Chemistry, 10(16), 1925–1945. https://doi.org/https://doi.org/10.4155/fmc-2018-0020
- Ghribia, L., Ghouilaa, H., Omrib, A., Besbesb, M., & Janneta, H. B. (2014). Antioxidant and anti-acetylcholinesterase activities of extracts and secondary metabolites from Acacia cyanophylla. Asian Pacific Journal of Tropical Biomedicine, 4(Suppl 1), S417–S423. https://doi.org/https://doi.org/10.12980/APJTB.4.2014C1038
- Gumushan Aktas, H., & Akgun, T. (2018). Naringenin inhibits prostate cancer metastasis by blocking voltage-gated sodium channels. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 106, 770–775. https://doi.org/https://doi.org/10.1016/j.biopha.2018.07.008
- Gopinath, K., & Sudhandiran, G. (2012). Naringin modulates oxidative stress and inflammation in 3-nitropropionic acid-induced neurodegeneration through the activation of nuclear factor-erythroid 2-related factor-2 signalling pathway. Neuroscience, 227, 134–143. https://doi.org/https://doi.org/10.1016/j.neuroscience.2012.07.060
- Hensbergen, A. W., van Willigen, D. M., van Beurden, F., van Leeuwen, P. J., Buckle, T., Schottelius, M., Maurer, T., Wester, H.-J., & van Leeuwen, F. W. B. (2020). Image-guided surgery: Are we getting the most out of small-molecule prostate-specific-membrane-antigen-targeted tracers? Bioconjugate Chemistry, 31(2), 375–395. https://doi.org/https://doi.org/10.1021/acs.bioconjchem.9b00758
- Ishizuya, Y., Uemura, M., Narumi, R., Tomiyama, E., Koh, Y., Matsushita, M., Nakano, K., Hayashi, Y., Wang, C., Kato, T., Hatano, K., Kawashima, A., Ujike, T., Fujita, K., Imamura, R., Adachi, J., Tomonaga, T., & Nonomura, N. (2020). The role of actinin-4 (ACTN4) in exosomes as a potential novel therapeutic target in castration-resistant prostate cancer. Biochemical and Biophysical Research Communications, 523(3), 588–594. https://doi.org/https://doi.org/10.1016/j.bbrc.2019.12.084
- Jackie, B., Sagar, S., Alamgir, H., Razowanul Md, F., Sumaiya, F., Emon, D., Hasan, M., Arafat, F., Mohammed, F., & Ramjan Ali, M. (2018). In silico molecular docking and ADME/T analysis of some selected isolated compounds of Phyllanthus emblica against type 2 diabetics. American Journal of Ethnomedicine, 05(02), 3–7. https://doi.org/https://doi.org/10.21767/2348-9502.100009
- Kannan, S., Poulsen, A., Yang, H. Y., Ho, M., Ang, S. H., Eldwin, T. S. W., Jeyaraj, D. A., Chennamaneni, L. R., Liu, B., Hill, J., Verma, C. S., & Nacro, K. (2015). Probing the binding mechanism of Mnk inhibitors by docking and molecular dynamics simulations. Biochemistry, 54(1), 32–46. https://doi.org/https://doi.org/10.1021/bi501261j
- Karthick, V., Nagasundaram, N., Doss, C. G. P., Chakraborty, C., Siva, R., Lu, A., Zhang, G., & Zhu, H. (2016). Virtual screening of the inhibitors targeting at the viral protein 40 of Ebola virus. Infectious Diseases of Poverty, 5(1), 1–10. https://doi.org/https://doi.org/10.1186/s40249-016-0105-1
- Khathi, S. P., Chandrasekaran, B., Karunanidhi, S., Tham, C. L., Kozielski, F., Sayyad, N., & Karpoormath, R. (2018). Design and synthesis of novel thiadiazole-thiazolone hybrids as potential inhibitors of the human mitotic kinesin Eg5. Bioorganic & Medicinal Chemistry Letters, 28(17), 2930–2938. https://doi.org/https://doi.org/10.1016/j.bmcl.2018.07.007
- Kim, H. J., Yong, H. I., Park, S., Kim, K., Kim, T. H., Choe, W., & Jo, C. (2014). Effect of atmospheric pressure dielectric barrier discharge plasma on the biological activity of naringin. Food Chemistry, 160, 241–245. https://doi.org/https://doi.org/10.1016/j.foodchem.2014.03.101
- Kohaar, I., Petrovics, G., & Srivastava, S. (2019). A rich array of prostate cancer molecular biomarkers: Opportunities and challenges. International Journal of Molecular Sciences, 20(8), 1813. https://doi.org/https://doi.org/10.3390/ijms20081813
- Kumar, N., Srivastava, R., Prakash, A., & Lynn, A. M. (2020). Structure-based virtual screening, molecular dynamics simulation and MM-PBSA toward identifying the inhibitors for two-component regulatory system protein NarL of Mycobacterium tuberculosis. Journal of Biomolecular Structure & Dynamics, 38(11), 3396–3410. https://doi.org/https://doi.org/10.1080/07391102.2019.1657499
- Lee, J. O., Yang, H., Georgescu, M. M., Cristofano, A. D., Maehama, T., Shi, Y., Dixon, J. E., Pandolfi, P., & Pavletich, N. P. (1999). Crystal structure of the PTEN tumor suppressor: Implications for its phosphoinositide phosphatase activity and membrane association. Cell, 99(3), 323–334. https://doi.org/https://doi.org/10.1016/S0092-8674(00)81663-3
- Lewinska, A., Siwak, J., Rzeszutek, I., & Wnuk, M. (2015). Diosmin induces genotoxicity and apoptosis in DU145 prostate cancer cell line. Toxicology In Vitro: An International Journal Published in Association with Bibra, 29(3), 417–425. https://doi.org/https://doi.org/10.1016/j.tiv.2014.12.005
- Li, H., Yang, B., Huang, J., Xiang, T., Yin, X., Wan, J., Luo, F., Zhang, L., Li, H., & Ren, G. (2013). Naringin inhibits growth potential of human triple-negative breast cancer cells by targeting β-catenin signaling pathway. Toxicology Letters, 220(3), 219–228. https://doi.org/https://doi.org/10.1016/j.toxlet.2013.05.006
- Manna, K., Das, U., Das, D., Kesh, S. B., Khan, A., Chakraborty, A., & Dey, S. (2015). Naringin inhibits gamma radiation-induced oxidative DNA damage and inflammation, by modulating p53 and NF-κB signaling pathways in murine splenocytes. Free Radical Research, 49(4), 422–439. https://doi.org/https://doi.org/10.3109/10715762.2015.1016018
- Naveed, M., Tehreem, S., Mubeen, S., Nadeem, F., Zafar, F., & Irshad, M. (2016). In-silico analysis of non-synonymous-SNPs of STEAP2: To provoke the progression of prostate cancer. Open Life Sciences, 11(1), 402–416. https://doi.org/https://doi.org/10.1515/biol-2016-0054
- Nishandhini, M., & Vinoth, M. (2012). Molecular dynamics and docking studies on PTEN protein. Discovery Life, 1, 2.
- Nithya, G., Ilakkia, A., & Sakthisekaran, D. (2015). In silico docking studies on the anti-cancer effect of thymoquinone on interaction with phosphatase and tensin homolog located on chromosome 10q23: A regulator of PI3K/AKT pathway. Asian Journal of Pharmaceutical and Clinical Research, 8(1), 192–195.
- Osanyinpeju, O. S., Bashary, R., Mittal, A., Vyas, M., Nayak, S. K., & Khatik, G. L. (2018). A comparative study of stereochemical effects of anti-prostate agents by molecular docking. Asian Journal of Pharmaceutical and Clinical Research, 11(14), 76–80. https://doi.org/https://doi.org/10.22159/ajpcr.2018.v11s2.28587
- Osguthorpe, D. J., & Hagler, A. T. (2011). Mechanism of androgen receptor antagonism by bicalutamide in the treatment of prostate cancer. Biochemistry, 50(19), 4105–4113. https://doi.org/https://doi.org/10.1021/bi102059z
- Park, S. J., Kufareva, I., & Abagyan, R. (2010). Improved docking, screening and selectivity prediction for small molecule nuclear receptor modulators using conformational ensembles. Journal of Computer-Aided Molecular Design, 24(5), 459–471. https://doi.org/https://doi.org/10.1007/s10822-010-9362-4
- Raha, S., Yumnam, S., Hong, G. E., Lee, H. J., Saralamma, V. V. G., Park, H.-S., Heo, J. D., Lee, S. J., Kim, E. H., Kim, J.-A., & Kim, G. S. (2015). Naringin induces autophagy-mediated growth inhibition by downregulating the PI3K/Akt/mTOR cascade via activation of MAPK pathways in AGS cancer cells. International Journal of Oncology, 47(3), 1061–1069. https://doi.org/https://doi.org/10.3892/ijo.2015.3095
- Razzaghi-Asl, N., Mirzayi, S., Mahnam, K., & Sepehri, S. (2018). Identification of COX-2 inhibitors via structure-based virtual screening and molecular dynamics simulation. Journal of Molecular Graphics & Modelling, 83, 138–152. https://doi.org/https://doi.org/10.1016/j.jmgm.2018.05.010
- Sahihi, M., & Ghayeb, Y. (2014). An investigation of molecular dynamics simulation and molecular docking: Interaction of citrus flavonoids and bovine β-lactoglobulin in focus. Computers in Biology and Medicine, 51, 44–50. https://doi.org/https://doi.org/10.1016/j.compbiomed.2014.04.022
- Sankar, M., Langeswaran, K., Jeyachandran, S., & Pandi, B. (2020). Screening of inhibitors as potential remedial against Ebolavirus infection: Pharmacophore-based approach. Journal of Biomolecular Structure and Dynamics, 30, 1–14. https://doi.org/https://doi.org/10.1080/07391102.2020.1715260.
- Selvaraj, C., & Singh, S. K. (2014). Validation of potential inhibitors for SrtA against Bacillus anthracis by combined approach of ligand-based and molecular dynamics simulation. Journal of Biomolecular Structure & Dynamics, 32(8), 1333–1349. https://doi.org/https://doi.org/10.1080/07391102.2013.818577
- Shahbaaz, M., Nkaule, A., & Christoffels, A. (2019). Designing novel possible kinase inhibitor derivatives as therapeutics against Mycobacterium tuberculosis: An in silico study. Scientific Reports, 9(1), 1–12. https://doi.org/https://doi.org/10.1038/s41598-019-40621-7
- Shaikh, M. S., Kanhed, A. M., Chandrasekaran, B., Palkar, M. B., Agrawal, N., Lherbet, C., Hampannavar, G. A., & Karpoormath, R. (2019). Discovery of novel N-methyl carbazole tethered rhodanine derivatives as direct inhibitors of Mycobacterium tuberculosis InhA. Bioorganic & Medicinal Chemistry Letters, 29(16), 2338–2344. https://doi.org/https://doi.org/10.1016/j.bmcl.2019.06.015
- Suryanarayanan, V., Rajavel, T., Devi, K. P., & Singh, S. K. (2018). Structure based identification and biological evaluation of novel and potent inhibitors of PCAF catalytic domain. International Journal of Biological Macromolecules, 120(Pt A), 823–834. https://doi.org/https://doi.org/10.1016/j.ijbiomac.2018.08.052
- Tajaldini, M., Samadi, F., Khosravi, A., Ghasemnejad, A., & Asadi, J. (2020). Protective and anticancer effects of orange peel extract and naringin in doxorubicin treated esophageal cancer stem cell xenograft tumor mouse model. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 121, 109594. https://doi.org/https://doi.org/10.1016/j.biopha.2019.109594
- Talapatra, S. K., Tham, C. L., Guglielmi, P., Cirilli, R., Chandrasekaran, B., Karpoormath, R., Carradori, S., & Kozielski, F. (2018). Crystal structure of the Eg5 - K858 complex and implications for structure-based design of thiadiazole-containing inhibitors. European Journal of Medicinal Chemistry, 156, 641–651. https://doi.org/https://doi.org/10.1016/j.ejmech.2018.07.006
- Tonry, C. L., Doherty, D., O’Shea, C., Morrissey, B., Staunton, L., Flatley, B., Shannon, A., Armstrong, J., & Pennington, S. R. (2015). Discovery and longitudinal evaluation of candidate protein biomarkers for disease recurrence in prostate cancer. Journal of Proteome Research, 14(7), 2769–2783. https://doi.org/https://doi.org/10.1021/acs.jproteome.5b00041
- Usha, T., Middha, S. K., Goyal, A. K., Karthik, M., Manoj, D. A., Faizan, S., Goyal, P., Prashanth, H., & Pande, V. (2014). Molecular docking studies of anti-cancerous candidates in Hippophae rhamnoides and Hippophae salicifolia. Journal of Biomedical Research, 28(5), 406–415. https://doi.org/https://doi.org/10.7555/JBR.28.20130110
- Varma, A. K., Patil, R., Das, S., Stanley, A., Yadav, L., & Sudhakar, A. (2010). Optimized hydrophobic interactions and hydrogen bonding at the target-ligand interface leads the pathways of drug-designing. PLoS One, 5(8), e12029. https://doi.org/https://doi.org/10.1371/journal.pone.0012029
- Vijayakumar, S., Manogar, P., Prabhu, S., & Sanjeevkumar Singh, R. A. (2018). Novel ligand-based docking; molecular dynamic simulations; and absorption, distribution, metabolism, and excretion approach to analyzing potential acetylcholinesterase inhibitors for Alzheimer’s disease. Journal of Pharmaceutical Analysis, 8(6), 413–420. https://doi.org/https://doi.org/10.1016/j.jpha.2017.07.006
- Wang, Z., Jacobson, O., Tian, R., Mease, R. C., Kiesewetter, D. O., Niu, G., Pomper, M. G., & Chen, X. (2018). Radioligand therapy of prostate cancer with a long-lasting prostate-specific membrane antigen targeting agent 90Y-DOTA-EB-MCG. Bioconjugate Chemistry, 29(7), 2309–2315. https://doi.org/https://doi.org/10.1021/acs.bioconjchem.8b00292
- Zhou, Y., Cai, S., Moutal, A., Yu, J., Gómez, K., Madura, C. L., Shan, Z., Pham, N. Y. N., Serafini, M. J., Dorame, A., Scott, D. D., François-Moutal, L., Perez-Miller, S., Patek, M., Khanna, M., & Khanna, R. (2019). The natural flavonoid naringenin elicits analgesia through inhibition of NaV1.8 voltage-gated sodium channels. ACS Chemical Neuroscience, 10(12), 4834–4846. https://doi.org/https://doi.org/10.1021/acschemneuro.9b00547
- Zhuang, X., Zhao, B., Liu, S., Song, F., Cui, F., Liu, Z., & Li, Y. (2016). Noncovalent interactions between superoxide dismutase and flavonoids studied by native mass spectrometry combined with molecular simulations. Analytical Chemistry, 88(23), 11720–11726. https://doi.org/https://doi.org/10.1021/acs.analchem.6b03359
- Zeng, L., Zhen, Y., Chen, Y., Zou, L., Zhang, Y., Hu, F., Feng, J., Shen, J., & Wei, B. (2014). Naringin inhibits growth and induces apoptosis by a mechanism dependent on reduced activation of NF‑κB/COX‑2‑caspase-1 pathway in HeLa cervical cancer cells. International Journal of Oncology, 45(5), 1929–1936. https://doi.org/https://doi.org/10.3892/ijo.2014.2617
- Zhang, Q., Li, R., Peng, E., Zhang, M., Liu, J., Wei, S., Wang, J., Wu, C., Gao, Y., & Pu, X. (2019). Identification of the active constituents and significant pathways of Guizhi-Shaoyao-Zhimu decoction for the treatment of diabetes mellitus based on molecular docking and network pharmacology. Combinatorial Chemistry & High Throughput Screening, 22(9), 584–598. https://doi.org/https://doi.org/10.2174/1386207322666191022101613
- Zhou, X., Yang, X., Sun, X., Xu, X., Li, X., Guo, Y., Wang, J., Li, X., Yao, L., Wang, H., & Shen, L. (2019). Effect of PTEN loss on metabolic reprogramming in prostate cancer cells. Oncology Letters, 17(3), 2856–2866. https://doi.org/https://doi.org/10.3892/ol.2019.9932